About
SEC Filings
Back


Form DEF 14A
FIBROCELL SCIENCE, INC. filed this Form DEF 14A on 04/29/2019
Document Outline
Entire Document (2898 KB)
Subdocument 1 - DEF 14A - DEF 14A
Page 1 - UNITED STATES
Page 2 - NOTICE OF 2019 ANNUAL MEETING
Page 3 - 405 Eagleview Blvd.
Page 4 - TABLE OF CONTENTS
Page 5 - This Notice of 2019 Annual Meeting of Stockholders and Proxy Statement (Proxy Statement) and our acc
Page 6 - NOTICE OF 2019 ANNUAL MEETING OF STOCKHOLDERS
Page 7 - Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
Page 8 - QUESTIONS AND ANSWERS
Page 9 - http://www.proxyvote.com.
Page 10 - What happens if additional matters are presented at the Annual Meeting?
Page 11 - Can I change my vote or revoke my proxy?
Page 12 - How many shares must be present or represented to conduct business at the Annual Meeting?
Page 13 - Who will count the votes?
Page 14 - PROPOSALS
Page 15 - Proposal No. 2: Approval of Our 2019 Equity Incentive Plan
Page 16 - Limited duration of existing plan
Page 17 - Options.
Page 18 - Adjustments
Page 19 - Incentive Stock Options
Page 20 - Withholding
Page 21 - Proposal No. 3: Ratification of Appointment of Independent Registered Public Accounting Firm
Page 22 - Proposal No. 4: Non-Binding Advisory Vote on Named Executive Officer Compensation
Page 23 - Proposal No. 5: Non-Binding Advisory Vote on the Frequency of Future Named Executive Officer Compens
Page 24 - Other Proposed Action
Page 25 - DIRECTORS AND EXECUTIVE OFFICERS
Page 26 - N/A
Page 27 - N/A
Page 28 - Executive Officers
Page 29 - STOCK OWNERSHIP
Page 30 - Section 16(a) Beneficial Ownership Reporting Compliance
Page 31 - CORPORATE GOVERNANCE AND BOARD MATTERS
Page 32 - Board Meetings
Page 33 - Audit Committee
Page 34 - Nominating and Corporate Governance Committee
Page 35 - Nomination of Director Candidates
Page 36 - Compensation Committee Interlocks and Insider Participation
Page 37 - Audit Committee Report
Page 38 - RELATED PARTY TRANSACTIONS
Page 39 - Participation in Series A Preferred Stock Offering
Page 40 - EXECUTIVE COMPENSATION
Page 41 - Employment Agreements with Named Executive Officers
Page 42 - 2018 Outstanding Equity Awards At Fiscal Year-End
Page 43 - N/A
Page 44 - Additional Narrative Disclosures
Page 45 - DIRECTOR COMPENSATION
Page 46 - 2018 Director Compensation
Page 47 - N/A
Page 48 - N/A
Page 49 - OUR EQUITY COMPENSATION PLANS
Page 50 - INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 51 - DELIVERY OF DOCUMENTS TO STOCKHOLDERS SHARING AN ADDRESS
Page 52 - AVAILABILITY OF ANNUAL REPORT ON FORM 10-K
Page 53 - STOCKHOLDER PROPOSALS AND DIRECTOR NOMINATIONS
Page 54 - Your vote is important. Even if you plan to attend the Annual Meeting, we urge you to submit your pr
Page 55 - Annex A
Page 56 - N/A
Page 57 - N/A
Page 58 - Committee
Page 59 - Grants
Page 60 - Termination of Employment or Service
Page 61 - Exercise of Options
Page 62 - Dividend Equivalents
Page 63 - Duration of SAR
Page 64 - Restrictions on Transfer
Page 65 - Amendment
Page 66 - Enforceability
Page 67 - N/A
Page 68 - N/A



Printer Friendly Version E-mail this page RSS E-mail Alerts Download Financial Tear Sheet